December 2, 2025 · Form 4 insider transaction
Galletta Christopher bought 4,225 shares of Trevi Therapeutics, Inc. at $0.51 per share, a transaction worth $2.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Includes 6,870 shares purchased through the Issuer's employee stock purchase plan.